πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 158 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10626129

Heteroaryl inhibitors of PDE4

Tetra Discovery Partners Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626393

Delivering CRISPR therapeutics with lipid nanoparticles

ARBUTUS BIOPHARMA CORPORATION Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626419

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626372

Methods and compositions for inducing hematopoietic cell differentiation

Fate Therapeutics, Inc. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626146

Ξ±4Ξ²7 thioether peptide dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626094

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626396

Antisense composition and method for treating muscle atrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626096

Azole derivatives as apelin receptor agonist

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626147

Cell penetrating peptides and methods of making and using thereof

Entrada Therapeutics, Inc. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626469

Rapid identification of microorganisms

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626111

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626145

Peptide with anti-obesity and anti-diabetes activity and use thereof

CAREGEN CO., LTD. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626173

Method for treating pathological angiogenesis by administering an antibody that inhibits A

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626087

Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the sa

The Board of Regents of the University of Texas System Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10596260

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10301626

Catalytic strands of minimal hammerhead ribozymes and methods of using the same

The Regents of the University of California Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238626

Therapeutic compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10081626

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9956267

Method of treating skeletal dysplasias using vessel dilator

United States Department of Veteran Affairs Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9944626

6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862684

Modulation of K2P channels

The Regents of the University of California Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862679

Potent and selective inhibitors of monoamine transporters; method of making; and use there

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862693

Compounds and methods of treating cancer

The Regents of the University of California Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856264

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

Medshine Discovery Inc. Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted